After decades of claiming that cannabis has no medicinal value, the U.S. government is finally admitting that cannabis can kill cancer cells.
Several scientific studies have given indications of these beneficial properties in the past, and this past April the US government’s National Institute on Drug Abuse (NIDA) revised their publications to suggest cannabis could shrink brain tumors by killing off cancer cells, stating, “marijuana can kill certain cancer cells and reduce the size of others.”
Research on marijuana’s potential as a medicine has been stifled for decades by federal restrictions, even though nearly half of the states and the District of Columbia have legalized medical marijuana in some form.
Although cannabis has been increasingly legalized by states, the federal government still classifies marijuana as a Schedule 1 drug — along with heroin and ecstasy — defining it as having no medical benefits and a potential for abuse.
The vast majority of the $1.4 billion spent on marijuana research, by the National Institute of Health, absurdly involves the study of abuse and addiction, with only $297 million being spent researching potential medical benefits.
Judging by the spending levels, it seems the feds have a vested interest in keeping public opinion of cannabis negative. Perhaps “Big Pharma” is utilizing their financial influence over politicians in an effort to maintain a stranglehold on the medical treatment market.
Other Cannabis Related New Articles: